Literature DB >> 21965223

Pulmonary embolism: CT signs and cardiac biomarkers for predicting right ventricular dysfunction.

T Henzler1, S Roeger, M Meyer, U J Schoepf, J W Nance, D Haghi, W E Kaminski, M Neumaier, S O Schoenberg, C Fink.   

Abstract

The aim of this study was to prospectively evaluate the accuracy of quantitative cardiac computed tomography (CT) parameters and two cardiac biomarkers (N-terminal-pro-brain natriuretic peptide (NT-pro-BNP) and troponin I), alone and in combination, for predicting right ventricular dysfunction (RVD) in patients with acute pulmonary embolism. 557 consecutive patients with suspected pulmonary embolism underwent pulmonary CT angiography. Patients with pulmonary embolism also underwent echocardiography and NT-pro-BNP/troponin I serum level measurements. Three different CT measurements were obtained (right ventricular (RV)/left ventricular (LV)(axial), RV/LV(4-CH) and RV/LV(volume)). CT measurements and NT-pro-BNP/troponin I serum levels were correlated with RVD at echocardiography. 77 patients with RVD showed significantly higher RV/LV ratios and NT-pro-BNP/troponin I levels compared to those without RVD (RV/LV(axial) 1.68 ± 0.84 versus 1.00 ± 0.21; RV/LV(4-CH) 1.52 ± 0.45 versus 1.01 ± 0.21; RV/LV(volume) 1.97 ± 0.53 versus 1.07 ± 0.52; serum NT-pro-BNP 6,372 ± 2,319 versus 1,032 ± 1,559 ng · L(-1); troponin I 0.18 ± 0.41 versus 0.06 ± 0.18 g · L(-1)). The area under the curve for the detection of RVD of RV/LV(axial), RV/LV(4-CH), RV/LV(volume), NT-pro-BNP and troponin I were 0.84, 0.87, 0.93, 0.83 and 0.70 respectively. The combination of biomarkers and RV/LV(volume) increased the AUC to 0.95 (RV/LV(volume) with NT-pro-BNP) and 0.93 (RV/LV(volume) with troponin I). RV/LV(volume) is the most accurate CT parameter for identifying patients with RVD. A combination of RV/LV(volume) with NT-pro-BNP or troponin I measurements improves the diagnostic accuracy of either test alone.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21965223     DOI: 10.1183/09031936.00088711

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  27 in total

1.  The efficacy of CT for detection of right ventricular dysfunction in acute pulmonary embolism, and comparison with cardiac biomarkers.

Authors:  Erdal İn; Ayşe Murat Aydın; Cengiz Özdemir; Sinem Nedime Sökücü; Mustafa Necati Dağlı
Journal:  Jpn J Radiol       Date:  2015-06-29       Impact factor: 2.374

2.  Heart rate in pulmonary embolism.

Authors:  Karsten Keller; Johannes Beule; Meike Coldewey; Wolfgang Dippold; Jörn Oliver Balzer
Journal:  Intern Emerg Med       Date:  2015-01-30       Impact factor: 3.397

3.  Right ventricular enlargement in acute pulmonary embolism derived from CT pulmonary angiography.

Authors:  Kanako K Kumamaru; Michael T Lu; Sanaz Ghaderi Niri; Andetta R Hunsaker
Journal:  Int J Cardiovasc Imaging       Date:  2013-03       Impact factor: 2.357

4.  Rapid on-site evaluation of routine biochemical parameters to predict right ventricular dysfunction in and the prognosis of patients with acute pulmonary embolism upon admission to the emergency room.

Authors:  Dong Jia; Fan Liu; Qin Zhang; Guang-Qiao Zeng; Xue-Lian Li; Gang Hou
Journal:  J Clin Lab Anal       Date:  2017-11-21       Impact factor: 2.352

5.  Pulmonary hypertension and right ventricular dysfunction in patients with left to right shunt coronary artery fistula: evaluation with cardiac CT.

Authors:  Yu-Pin Chang; Si-Wa Chan; Jyh-Wen Chai; Jeon-Ho Chen; Yun-Ching Fu; Jian-Ling Chen; Yen-Ting Lin; Ming-Chih Chen; Clayton Chi-Chang Chen
Journal:  Int J Cardiovasc Imaging       Date:  2016-03-25       Impact factor: 2.357

Review 6.  Early management of patients with acute heart failure: state of the art and future directions. A consensus document from the society for academic emergency medicine/heart failure society of America acute heart failure working group.

Authors:  Sean Collins; Alan B Storrow; Nancy M Albert; Javed Butler; Justin Ezekowitz; G Michael Felker; Gregory J Fermann; Gregg C Fonarow; Michael M Givertz; Brian Hiestand; Judd E Hollander; David E Lanfear; Phillip D Levy; Peter S Pang; W Frank Peacock; Douglas B Sawyer; John R Teerlink; Daniel J Lenihan
Journal:  J Card Fail       Date:  2014-07-18       Impact factor: 5.712

7.  Prognostic implications of heart failure with preserved ejection fraction in patients with an exacerbation of chronic obstructive pulmonary disease.

Authors:  Robert Marcun; Ivan Stankovic; Radosav Vidakovic; Jerneja Farkas; Sasa Kadivec; Biljana Putnikovic; Ivan Ilic; Aleksandar N Neskovic; Mitja Lainscak
Journal:  Intern Emerg Med       Date:  2015-09-30       Impact factor: 3.397

Review 8.  Early management of patients with acute heart failure: state of the art and future directions--a consensus document from the SAEM/HFSA acute heart failure working group.

Authors:  Sean P Collins; Alan B Storrow; Phillip D Levy; Nancy Albert; Javed Butler; Justin A Ezekowitz; G Michael Felker; Gregory J Fermann; Gregg C Fonarow; Michael M Givertz; Brian Hiestand; Judd E Hollander; David E Lanfear; Peter S Pang; W Frank Peacock; Douglas B Sawyer; John R Teerlink; Daniel J Lenihan
Journal:  Acad Emerg Med       Date:  2014-11-25       Impact factor: 3.451

9.  Choice of marker for assessment of RV dysfunction in acute pulmonary embolism : NT-proBNP, pulmonary artery systolic pressure, mean arterial pressure, or blood pressure index.

Authors:  H Ates; I Ates; H Kundi; F M Yilmaz
Journal:  Herz       Date:  2016-12-13       Impact factor: 1.443

10.  New generation aspiration catheter: Feasibility in the treatment of pulmonary embolism.

Authors:  Wolf E Heberlein; Mollie E Meek; Omar Saleh; James C Meek; Shelly Y Lensing; William C Culp
Journal:  World J Radiol       Date:  2013-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.